Kinta Alexander | Director of Infection and Prevention and Control
New York City Health and Hospitals/Harlem

Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 14:30

Panel: From New Drug Developments to New Approaches: Tackling the Emerging Threat of Anti-fungal Resistance

Moderator: Rob Purdie, Founder and Managing Director, Mycology Advocacy, research and Education (MyCARE)

Carol Munro, Professor, University of Aberdeen

Kinta Alexander, Director of Infection and Prevention and Control, New York City Health and Hospitals/Harlem

×

Kinta Alexander / Panel: From New Drug Developments to New Approaches: Tackling the Emerging Threat of Anti-fungal Resistance

Kinta Alexander, Director of Infection and Prevention and Control,
New York City Health and Hospitals/Harlem

Demonstrating an unwavering commitment to the field of infection prevention, Dr. Alexander, Director of Infection Prevention and Control and CEO of MICRO Consulting Corporation since 2019, has charted a professional trajectory highlighted by groundbreaking initiatives, notably at Mount Sinai...

CloseMore

Afreenish Amir, Project Director National Fungal Disease Surveillance System, National Institute of Health (Pakistan)

×

Afreenish Amir / Panel: From New Drug Developments to New Approaches: Tackling the Emerging Threat of Anti-fungal Resistance

Afreenish Amir, Project Director National Fungal Disease Surveillance System,
National Institute of Health (Pakistan)

Dr Afreenish Amir (MBBS, M.Phil, PhD (Microbiology), MPH, CHPE, DHM, PhD Public Health) has over sixteen years of experience in clinical microbiology and infectious diseases. She is working on implementation of National Action Plan on One Health Antimicrobial Resistance, Laboratory systems, AMR and ...

CloseMore